Credit Suisse

Pfandbriefbank Schweizerischer Hypothekarinstitute tapped two Swiss covered bonds on Tuesday, in what was likely the final trades of the year. The shorter 10 year Pfandbrief tenor offered a 0.29% yield, an early Christmas present to investors forced far along the curve throughout the year.

Calcium aluminate maker Kerneos has cancelled its proposed €445m term loan ‘B’ refinancing deal, with French industrial minerals maker Imersys set to buy the firm from sponsor Astorg Partners.

Chinese selfie app maker Meitu wrapped up its IPO at the bottom of guidance last week, raising HK$4.9bn ($631.5m) in fresh funds.

Two firms with Asian links canned their US floats this week, with InnoLight Technology Corp and Ironshore announcing they have dropped their listing plans.

Chinese e-commerce solutions firm Baozun has raised $73.5m after closing a follow-on placement multiple times covered, despite its stock having a wobbly start to the week.

Credit Suisse updated the market on the progress of its strategic turnaround on Wednesday, lowering its revenue targets and stepping up its cost cutting. The majority of the additional cost cutting will hit global markets, while in investment banking it has already cut down its reliance on leveraged finance.

BNP Paribas has hired Harsh Agarwal from Credit Suisse, adding the new arrival to its corporate DCM team.

Apollo-owned French glass maker Verallia launched a €1.375bn term loan refinancing with a lender call on Thursday afternoon, its first deal since its failed €500m pay-if-you-can dividend recap offering in October.

Credit Suisse has lowered profit targets for its Asia Pacific division amid a slump in volumes and capital markets activity, the bank said at its investor day this week.

Banca Monte dei Paschi’s shares leapt 7% on Wednesday morning, on growing hopes that a way will be found for the Italian state to strengthen its balance sheet, enabling it to achieve a €5bn capital raising demanded by the European Central Bank and avoid a bail-in.

China's Baozun opened books on Monday morning for its first follow-on offering since its Nasdaq IPO in May last year, and is looking to raise around $85m.

Catalent Pharma and Thomas Cook — a reverse Yankee issuer and a UK holidays operator — on Thursday released guidance for high yield deals amounting some €900m in a market that has been mute since November 15.